Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 23;7(1):13781.
doi: 10.1038/s41598-017-13739-9.

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Affiliations

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Eke G Gruppen et al. Sci Rep. .

Abstract

Trimethylamine-N-Oxide (TMAO) is a microbiome-related metabolite that is cleared by the kidney and linked to renal function. We explored the relationship between TMAO and all-cause mortality, and determined whether this association was modified by renal function. A prospective study was performed among PREVEND participants to examine associations of plasma TMAO with all-cause mortality. After median follow-up of 8.3 years in 5,469 participants, 322 subjects died. TMAO was positively associated with age, body mass index, type 2 diabetes mellitus and inversely with estimated glomerular filtration rate (eGFRcreatcysC)(all P < 0.001). Subjects in the highest versus lowest TMAO quartile had a crude 1.86-fold higher mortality risk (Ptrend < 0.001). After adjustment for several risk factors, TMAO remained associated with all-cause mortality [HR:1.36 (95% CI, 0.97-1.91),Ptrend = 0.016]. This association was lost after further adjustment for urinary albumin excretion and eGFR [HR:1.15 (95% CI, 0.81-1.64),Ptrend = 0.22]. The association of TMAO with mortality was modified by eGFR in crude and age- and sex-adjusted analyses (interaction P = 0.002). When participants were stratified by renal function (eGFR < vs. ≥90 mL/min/1.73 m2), TMAO was associated with all-cause mortality only in subjects with eGFR <90 mL/min/1.73 m2 [adjusted HR:1.18 (95% CI, 1.02-1.36),P = 0.023]. In conclusion, TMAO is associated with all-cause mortality, particularly in subjects with eGFR <90 mL/min/1.73 m2.

PubMed Disclaimer

Conflict of interest statement

E.G., M.A.C., E.J.J. and J.D.O. are employees of LabCorp.

Figures

Figure 1
Figure 1
Kaplan-Meier curves of all-cause mortality according to quartiles of trimethylamine N-oxide (TMAO), P ≤ 0.001by log-rank test.
Figure 2
Figure 2
Association between trimethylamine N-oxide (TMAO) and all-cause mortality. Data were fit by a Cox proportional hazards regression model that was based on restricted cubic splines and adjusted for age and sex. The reference standard was mean TMAO level of 2.92 µM (antilog). The gray areas represent 95% CIs.
Figure 3
Figure 3
Mediation analysis on the association of TMAO with all-cause mortality. A, b and c are the standard regression coefficients between variables. The indirect effect is calculated as a * b. Total effect (c) is a * b + c’. Magnitude of mediation is calculated as indirect effect divided by total effect.

References

    1. Zeisel SH, da Costa KA. Choline: An essential nutrient for public health. Nutr Rev. 2009;67:615–623. doi: 10.1111/j.1753-4887.2009.00246.x. - DOI - PMC - PubMed
    1. Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63. doi: 10.1038/nature09922. - DOI - PMC - PubMed
    1. Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med, doi:10.1038/nm.3145 (2013). - PMC - PubMed
    1. Tang WH, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575–1584. doi: 10.1056/NEJMoa1109400. - DOI - PMC - PubMed
    1. Bennett BJ, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49–60. doi: 10.1016/j.cmet.2012.12.011. - DOI - PMC - PubMed

MeSH terms